Literature DB >> 23449771

Does primary surgical closure of the patent ductus arteriosus in infants <1500 g or ≤32 weeks' gestation reduce the incidence of necrotizing enterocolitis?

Wendy H Yee1, Jeanne Scotland.   

Abstract

BACKGROUND: The hemodynamic perturbation related to patent ductus arteriosus (PDA) is associated with a higher risk of necrotizing enterocolitis (NEC).
OBJECTIVE: To determine whether primary surgical closure, as compared with treatment with indomethacin or exposure to prophylactic indomethacin, reduces the incidence of NEC in preterm infants <1500 g and/or ≤32 weeks' gestation with clinically and echocardiogram-identified PDA.
METHODS: The literature was reviewed using the methodology for systematic reviews for the Consensus of Science adapted from the American Heart Association's International Liaison Committee on Resuscitation.
RESULTS: Ten studies were reviewed. The incidence of NEC was not lower in infants who underwent primary surgery for closure of the PDA compared with infants treated with indomethacin or infants exposed to prophylactic indomethacin (level of evidence 2).
CONCLUSION: Primary surgical closure of the PDA cannot be recommended as an intervention to decrease the incidence of NEC in infants <1500 g and/or ≤32 weeks' gestation.
BACKGROUND: The hemodynamic perturbation related to patent ductus arteriosus (PDA) is associated with a higher risk of necrotizing enterocolitis (NEC).
OBJECTIVE: To determine whether primary surgical closure, as compared with treatment with indomethacin or exposure to prophylactic indomethacin, reduces the incidence of NEC in preterm infants <1500 g and/or ≤32 weeks’ gestation with clinically and echocardiogram-identified PDA.
METHODS: The literature was reviewed using the methodology for systematic reviews for the Consensus of Science adapted from the American Heart Association’s International Liaison Committee on Resuscitation.
RESULTS: Ten studies were reviewed. The incidence of NEC was not lower in infants who underwent primary surgery for closure of the PDA compared with infants treated with indomethacin or infants exposed to prophylactic indomethacin (level of evidence 2).
CONCLUSION: Primary surgical closure of the PDA cannot be recommended as an intervention to decrease the incidence of NEC in infants <1500 g and/or ≤32 weeks’ gestation.

Entities:  

Keywords:  Necrotizing enterocolitis; Patent ductus arteriosus; Preterm infant; Primary surgery

Year:  2012        PMID: 23449771      PMCID: PMC3287088     

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN: 1205-7088            Impact factor:   2.253


  19 in total

Review 1.  Mechanisms regulating the ductus arteriosus.

Authors:  Ronald I Clyman
Journal:  Biol Neonate       Date:  2006-06-01

2.  Abnormal renal and splanchnic arterial Doppler pattern in premature babies with symptomatic patent ductus arteriosus.

Authors:  S N Wong; R N Lo; P W Hui
Journal:  J Ultrasound Med       Date:  1990-03       Impact factor: 2.153

3.  A randomized, controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth.

Authors:  G Cassady; D T Crouse; J W Kirklin; M J Strange; C H Joiner; G Godoy; G T Odrezin; G R Cutter; J K Kirklin; A D Pacifico
Journal:  N Engl J Med       Date:  1989-06-08       Impact factor: 91.245

4.  Management of patent ductus arteriosus: a comparison of operative v pharmacologic treatment.

Authors:  S B Palder; M Z Schwartz; K R Tyson; C C Marr
Journal:  J Pediatr Surg       Date:  1987-12       Impact factor: 2.545

Review 5.  Necrotising enterocolitis.

Authors:  Patricia W Lin; Barbara J Stoll
Journal:  Lancet       Date:  2006-10-07       Impact factor: 79.321

6.  Patent ductus arteriosus in very low birthweight infants: complications of pharmacological and surgical treatment.

Authors:  P S Koehne; G Bein; V Alexi-Meskhishvili; Y Weng; C Bührer; M Obladen
Journal:  J Perinat Med       Date:  2001       Impact factor: 1.901

Review 7.  Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.

Authors:  D F Stroup; J A Berlin; S C Morton; I Olkin; G D Williamson; D Rennie; D Moher; B J Becker; T A Sipe; S B Thacker
Journal:  JAMA       Date:  2000-04-19       Impact factor: 56.272

8.  Patent ductus arteriosus, indomethacin and necrotizing enterocolitis in very low birth weight infants: a population-based study.

Authors:  Shaul Dollberg; Ayala Lusky; Brian Reichman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2005-02       Impact factor: 2.839

9.  Necrotizing enterocolitis and gastrointestinal complications after indomethacin therapy and surgical ligation in premature infants with patent ductus arteriosus.

Authors:  Donough J O'Donovan; Arlina Baetiong; Karen Adams; Ann Chen; E O'Brian Smith; James M Adams; Leonard E Weisman
Journal:  J Perinatol       Date:  2003-06       Impact factor: 2.521

10.  Effects of patent ductus arteriosus on left ventricular output and organ blood flows in preterm infants with respiratory distress syndrome treated with surfactant.

Authors:  S Shimada; T Kasai; M Konishi; T Fujiwara
Journal:  J Pediatr       Date:  1994-08       Impact factor: 4.406

View more
  3 in total

1.  Relationship Between Hemodynamically Significant Ductus Arteriosus and Ischemia-Modified Albumin in Premature Infants.

Authors:  Hasan Kahveci; Cüneyt Tayman; Fuat Laloğlu; Nazan Kavas; Murat Ciftel; Osman Yılmaz; Esra Laloğlu; Abdulah Erdil; Hülya Aksoy; Salih Aydemir
Journal:  Indian J Clin Biochem       Date:  2015-09-15

2.  Impact of umbilical cord milking and pasteurized donor human milk on necrotizing enterocolitis: a retrospective review.

Authors:  Mehtab K Sekhon; Bradley A Yoder
Journal:  BMC Pediatr       Date:  2018-05-08       Impact factor: 2.125

Review 3.  Recent advances in understanding necrotizing enterocolitis.

Authors:  Mashriq Alganabi; Carol Lee; Edoardo Bindi; Bo Li; Agostino Pierro
Journal:  F1000Res       Date:  2019-01-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.